Investor Presentation: First Nine Months of 2020
35
Investor presentation
First nine months of 2020
Novo NordiskⓇ
People with diabetes have increased mortality risk with eight years
shorter life expectancy, highlighting the importance of innovation
Diabetes is associated with shorter life expectancy
and lower quality of life
463
•
Life expectancy 8 years shorter¹
Diabetes
•
Driven by 200% increased risk of all
cause mortality¹
The unmet need remains large within diabetes
101
Untreated (million)
Treated with competitors' products (million)
Treated with Novo Nordisk' products (million)
CVD
•
70% of people with diabetes die from
atherosclerotic CVD²
•
150% increase in risk of stroke³
•
Higher likelihood of neuropathy,
Organs
retinopathy, limb amputation, cancer
and cognitive dysfunction4
183
30
Diabetic
population5
56
24
3
Other OAD
Insulin
Branded OAD
GLP-1
1 Diabetes Care 2017 Mar; 40 (3): 338-345; 2 https://www.who.int/cardiovascular_diseases/en/; 3 https://www.diabetes.org/diabetes/complications/stroke.; CVD: Cardiovascular disease; OAD: Oral anti-diabetic;
4Diabetes Care2005 Jan;28(1):164-176 5 IDF diabetes world atlas, 2017, 8th editionView entire presentation